At IgGnosis, we pioneer next-generation diagnostics for multiple sclerosis (MS), leveraging breakthrough IgG biomarker analysis to provide early, accurate, and non-invasive detection. Our mission is to empower patients and clinicians with precise insights into disease progression and treatment efficacy, revolutionizing MS care through science, innovation, and accessibility.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.